Nalpropion Pharmaceuticals, Inc. Employee Directory
PharmaceuticalsCalifornia, United States51-200 Employees
Nalpropion Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of weight loss, operating within the pharmaceutical manufacturing industry. The firm was established in 2018 as a joint venture among Currax Holdings LLC, Highbridge Capital Management, LLC, and Whitebox Advisors LLC, with the purpose of acquiring the commercial assets of Orexigen. Located in San Diego, California, the company emphasizes a patient-centered approach and a fast-paced environment that supports innovation and career growth. In September 2019, Currax Pharmaceuticals LLC announced the acquisition of Nalpropion, marking a notable development in its corporate trajectory.